Silence Therapeutics
Presence
Silence Therapeutics is a company listed under the stock ticker SLN (GB).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Silence Therapeutics
- Craig Tooman, President and Chief Executive Officer
- Ian Ross, Non-Executive Chairman of the Board
- Dave Lemus, Non-Executive Director
Popular executive movements at Silence Therapeutics
- Alistair Gray, Non-Executive Director, will retire on May 1, 2024 (posted on April 30 2024).
- Marie Wikström Lindholm, who was Senior Vice President and Head of Molecular Design, is promoted to Chief Scientific Officer (posted on December 3 2023).
- Curtis Rambaran, who was Vice President and Head of Clinical Science, is promoted to Chief Medical Officer (posted on December 3 2023).
Create your alert
to follow the executive moves at Silence Therapeutics.
Pharmaceuticals
Silence Therapeutics has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Silence Therapeutics
- Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
- Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
- Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
- Silence Therapeutics Reports Second Quarter 2023 Results
- Silence Therapeutics | Press Coverage
Social media about Silence Therapeutics
- Silence Therapeutics on Wikipedia, Google News & Yahoo Finance
- Silence Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Craig Tooman 
Call Silence Therapeutics at +44 203...
